跳至主要内容
临床试验/NL-OMON33232
NL-OMON33232已完成不适用

Macular Edema following cataract surgery in Diabetic type 2 patients - DME & Cataract

Oogziekenhuis Rotterdam0 个研究点目标入组 170 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
170

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Informed consent
  • - Cataract
  • - Diabetes Mellitus type 2
  • - Mild to moderate non-proliferative diabetic retinopathy

排除标准

  • - Severity of cataract obstructing ophthalmic inspection (i.e. NO5, NC5, NO6, NC6, C5, P5) and/or (sufficiently accurate) OCT measurements (i.e. a Signal Strength Index < 35).
  • - Any other corneal, media, retinal or optic nerve disorder, except stage I dry ARMD
  • - Clinically significant macular edema
  • - Pregnant, no active birth control
  • - Use of Diamox
  • - Use of Avandia (rosiglitazone)
  • - Use of oral steroids
  • - Use of Coumarin derivatives and heparin derivatives
  • - Status after ablatio retina/vitrectomy
  • - History of steroid response

研究者

发起方
Oogziekenhuis Rotterdam

相似试验

Macular Edema following cataract surgery in Diabetic... | 临床试验